Definition: A microarray is a small, flat substrate carrying an ordered grid of microscopic probe features, each containing a known biological molecule, that is used to measure many molecular targets ...
An international research team led by the University of Vienna has succeeded in developing a new version of RNA building blocks with higher chemical reactivity and photosensitivity. This can ...
Nucleic acid photolithography is the only microarray fabrication process that has demonstrated chemical versatility accommodating any type of nucleic acid. The current approach to RNA microarray ...
Marginalized racial and ethnic groups, women, and other historically disenfranchised populations are substantially underrepresented in clinical trials, despite increasing concern about this issue ...
Spectrum Solutions’ offerings enhanced by including CLIA/CAP laboratory testing, custom assay development, and manufacturing of industry-leading microarray chip technology. These valuable assets, ...
The acquisition of the Arizona-based microarray solutions company extends SCHOTT’s manufacturing presence in the United States and strengthens its bioscience capabilities. Customers will benefit from ...
Copy number variation (CNV) assessment is a critical component of precision medicine in almost all cancer types. For instance, copy number gain is a well described drug resistance mechanism to ...
Age Dependency of the Prognostic Impact of Tumor Genomics in Localized Resectable MYCN-Nonamplified Neuroblastomas. Report From the SIOPEN Biology Group on the LNESG Trials and a COG Validation Group ...
In order to derive the most accurate numbers possible for clinical trial success rates by phase and therapeutic area, a group of authors from MIT analyzed a mountain of data on drugs and vaccines from ...
Clinical trials are under way around the world, including in Australia, testing COVID-19 vaccines and treatments. These clinical trials largely fall into two groups. With observational studies, ...
Robust panel enables accurate and comprehensive constitutional genetic aberration screening in one assay Oxford, UK, 30 January 2020 – Oxford Gene Technology (OGT), A Sysmex Group Company, has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results